95 related articles for article (PubMed ID: 9444787)
1. Expression of p53 in glioblastoma multiforme cells: relationship to survival, proliferation and glycosylation.
Ehrmann J; Kolár Z; Kala M; Vojtĕsek B; Komenda S
Cesk Patol; 1995 Aug; 31(3):87-91. PubMed ID: 9444787
[TBL] [Abstract][Full Text] [Related]
2. Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy.
Grunnet ML; O'Neill A; Gilbert M; Hellman R
Clin Neuropathol; 2000; 19(5):230-4. PubMed ID: 11048748
[TBL] [Abstract][Full Text] [Related]
3. Correlation of proliferating cell nuclear antigen assessment, histologic parameters and age with survival in patients with glioblastoma multiforme.
Karkavelas G; Mavropoulou S; Fountzilas G; Christoforidou V; Karavelis A; Foroglou G; Papadimitriou C
Anticancer Res; 1995; 15(2):531-6. PubMed ID: 7763035
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic localization of wild-type p53 in glioblastomas correlates with expression of vimentin and glial fibrillary acidic protein.
Sembritzki O; Hagel C; Lamszus K; Deppert W; Bohn W
Neuro Oncol; 2002 Jul; 4(3):171-8. PubMed ID: 12084347
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in astrocytomas: relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival.
Ehrmann J; Kolár Z; Vojtĕsek B; Kala M; Komenda S; Oulton A
Neoplasma; 1997; 44(5):299-304. PubMed ID: 9473789
[TBL] [Abstract][Full Text] [Related]
6. CDC25B, Ki-67, and p53 expressions in reactive gliosis and astrocytomas.
Suren D; Isiksacan Ozen O
J BUON; 2013; 18(4):1006-11. PubMed ID: 24344030
[TBL] [Abstract][Full Text] [Related]
7. Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value.
Cunningham JM; Kimmel DW; Scheithauer BW; O'Fallon JR; Novotny PJ; Jenkins RB
J Neurosurg; 1997 Jan; 86(1):121-30. PubMed ID: 8988090
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas.
Kordek R; Biernat W; Debiec-Rychter M; Alwasiak J; Liberski PP
Pathol Res Pract; 1996 Mar; 192(3):205-9. PubMed ID: 8739466
[TBL] [Abstract][Full Text] [Related]
9. [Study on p53 protein expression, cell proliferation and apoptosis in benign and malignant brain tumors].
Yu S; Pu P; Jiang D
Zhonghua Bing Li Xue Za Zhi; 1997 Oct; 26(5):293-6. PubMed ID: 10374339
[TBL] [Abstract][Full Text] [Related]
10. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
Georgescu CV; Săftoiu A; Georgescu CC; Ciurea R; Ciurea T
J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of PCNA, Ki67, AgNOR and p53 expression in brain glial tumors].
Berny W; Weiser A; Markowska-Woyciechowska A; Jarmundowicz W; Zub W; Załuski R
Neurol Neurochir Pol; 2004; 38(6):457-63. PubMed ID: 15654669
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas.
Bouvier-Labit C; Chinot O; Ochi C; Gambarelli D; Dufour H; Figarella-Branger D
Neuropathol Appl Neurobiol; 1998 Oct; 24(5):381-8. PubMed ID: 9821169
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of tumor markers in patients with glioblastoma multiforme: analysis of 32 patients and review of the literature.
Reavey-Cantwell JF; Haroun RI; Zahurak M; Clatterbuck RE; Parker RJ; Mehta R; Fruehauf JP; Brem H
J Neurooncol; 2001 Dec; 55(3):195-204. PubMed ID: 11859975
[TBL] [Abstract][Full Text] [Related]
14. ATM and p53 combined analysis predicts survival in glioblastoma multiforme patients: A clinicopathologic study.
Romano FJ; Guadagno E; Solari D; Borrelli G; Pignatiello S; Cappabianca P; Del Basso De Caro M
J Cell Biochem; 2018 Jun; 119(6):4867-4877. PubMed ID: 29369420
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of p53 protein expression in glioblastoma.
Birner P; Piribauer M; Fischer I; Gatterbauer B; Marosi C; Ungersböck K; Rössler K; Budka H; Hainfellner JA
Oncol Rep; 2002; 9(4):703-7. PubMed ID: 12066196
[TBL] [Abstract][Full Text] [Related]
16. Proliferation- and apoptosis-related proteins in intracranial ependymomas: an immunohistochemical analysis.
Verstegen MJ; Leenstra DT; Ijlst-Keizers H; Bosch DA
J Neurooncol; 2002 Jan; 56(1):21-8. PubMed ID: 11949823
[TBL] [Abstract][Full Text] [Related]
17. Classification of microvascular patterns via cluster analysis reveals their prognostic significance in glioblastoma.
Chen L; Lin ZX; Lin GS; Zhou CF; Chen YP; Wang XF; Zheng ZQ
Hum Pathol; 2015 Jan; 46(1):120-8. PubMed ID: 25455996
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
19. Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation.
Haapasalo H; Isola J; Sallinen P; Kalimo H; Helin H; Rantala I
Am J Pathol; 1993 May; 142(5):1347-51. PubMed ID: 7684193
[TBL] [Abstract][Full Text] [Related]
20. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]